Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

Michael J Gale, Jr, Marcus J Korth, Michael G Katze
{"title":"Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance","authors":"Michael J Gale, Jr,&nbsp;Marcus J Korth,&nbsp;Michael G Katze","doi":"10.1016/S0928-0197(98)00034-8","DOIUrl":null,"url":null,"abstract":"<div><p><strong>Background:</strong> Chronic infection with hepatitis C virus (HCV) is associated with progressive liver damage, including the development of cirrhosis and hepatocellular carcinoma, and HCV is a leading cause of liver dysfunction worldwide. The current therapy for chronic HCV infection, interferon-<em>α</em> (IFN), is effective in a minority of HCV-infected patients. Several studies have demonstrated a correlation between therapeutic outcome and the amino acid sequence of a small region of the HCV non-structural 5A (NS5A) gene product. It has been suggested that this region, termed the interferon sensitivity-determining region (ISDR), may mediate IFN resistance by directly interacting with one or more cellular proteins associated with the IFN-mediated antiviral response.</p><p><strong>Objectives:</strong> In an attempt to define the molecular mechanism by which the NS5A protein and the ISDR might contribute to HCV resistance to IFN, we examined whether NS5A could regulate the IFN-induced protein kinase, PKR, a primary mediator of the IFN-induced antiviral response.</p><p><strong>Study design:</strong> Multiple approaches, including in vitro assays using recombinant proteins, the transfection of recombinant clones into cultured cells, and in vivo studies in yeast, were used to examine the interaction of NS5A with PKR, as well as the functional significance of the interaction. An ISDR deletion mutant was prepared to evaluate the importance of the ISDR in mediating the NS5A–PKR interaction and the requirement of this region for PKR inhibition.</p><p><strong>Results:</strong> NS5A repressed PKR activity through a direct interaction with the protein kinase catalytic domain. Both PKR repression and interaction required the presence of the ISDR.</p><p><strong>Conclusions:</strong> Inactivation of PKR may be one mechanism by which HCV avoids the antiviral effects of IFN. Thus, therapeutic strategies designed to block the NS5A–PKR interaction may increase the efficacy of IFN therapy in HCV-infected individuals.</p></div>","PeriodicalId":79479,"journal":{"name":"Clinical and diagnostic virology","volume":"10 2","pages":"Pages 157-162"},"PeriodicalIF":0.0000,"publicationDate":"1998-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-0197(98)00034-8","citationCount":"181","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and diagnostic virology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928019798000348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 181

Abstract

Background: Chronic infection with hepatitis C virus (HCV) is associated with progressive liver damage, including the development of cirrhosis and hepatocellular carcinoma, and HCV is a leading cause of liver dysfunction worldwide. The current therapy for chronic HCV infection, interferon-α (IFN), is effective in a minority of HCV-infected patients. Several studies have demonstrated a correlation between therapeutic outcome and the amino acid sequence of a small region of the HCV non-structural 5A (NS5A) gene product. It has been suggested that this region, termed the interferon sensitivity-determining region (ISDR), may mediate IFN resistance by directly interacting with one or more cellular proteins associated with the IFN-mediated antiviral response.

Objectives: In an attempt to define the molecular mechanism by which the NS5A protein and the ISDR might contribute to HCV resistance to IFN, we examined whether NS5A could regulate the IFN-induced protein kinase, PKR, a primary mediator of the IFN-induced antiviral response.

Study design: Multiple approaches, including in vitro assays using recombinant proteins, the transfection of recombinant clones into cultured cells, and in vivo studies in yeast, were used to examine the interaction of NS5A with PKR, as well as the functional significance of the interaction. An ISDR deletion mutant was prepared to evaluate the importance of the ISDR in mediating the NS5A–PKR interaction and the requirement of this region for PKR inhibition.

Results: NS5A repressed PKR activity through a direct interaction with the protein kinase catalytic domain. Both PKR repression and interaction required the presence of the ISDR.

Conclusions: Inactivation of PKR may be one mechanism by which HCV avoids the antiviral effects of IFN. Thus, therapeutic strategies designed to block the NS5A–PKR interaction may increase the efficacy of IFN therapy in HCV-infected individuals.

丙型肝炎病毒NS5A蛋白对PKR蛋白激酶的抑制:干扰素耐药的潜在机制
背景:慢性丙型肝炎病毒(HCV)感染与进行性肝损害相关,包括肝硬化和肝细胞癌的发展,HCV是世界范围内肝功能障碍的主要原因。目前治疗慢性HCV感染的干扰素-α (IFN)对少数HCV感染患者有效。一些研究已经证明了治疗结果与HCV非结构5A (NS5A)基因产物小区域氨基酸序列之间的相关性。这一区域被称为干扰素敏感性决定区(ISDR),可能通过与IFN介导的抗病毒反应相关的一种或多种细胞蛋白直接相互作用介导IFN耐药性。目的:为了确定NS5A蛋白和ISDR可能促进HCV对IFN耐药的分子机制,我们研究了NS5A是否可以调节IFN诱导的蛋白激酶PKR, PKR是IFN诱导的抗病毒反应的主要介质。研究设计:采用重组蛋白体外实验、重组克隆转染培养细胞、酵母体内实验等多种方法,研究NS5A与PKR的相互作用及其功能意义。制备了一个ISDR缺失突变体,以评估ISDR在介导NS5A-PKR相互作用中的重要性以及该区域对PKR抑制的要求。结果:NS5A通过与蛋白激酶催化结构域的直接相互作用抑制PKR活性。PKR抑制和相互作用都需要ISDR的存在。结论:PKR失活可能是HCV避免IFN抗病毒作用的一种机制。因此,设计阻断NS5A-PKR相互作用的治疗策略可能会增加IFN治疗hcv感染者的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信